Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Korpanty%2C+Grzegorz+J%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Korpanty%2C+Grzegorz+J%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Korpanty%2C+Grzegorz+J%22&type=Person&sort=year
PubPharm (9)
1
A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer : IND.210, a Canadian Cancer Trials Group Trial
enthalten in:
Clinical colorectal cancer
| 2018
von
Jonker, D.
|
Tang, P.
|
Kennecke, H.
| +16
Wird geladen...
2
Canadian Cancer Trials Group (CCTG) IND211 : A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2018
von
Bradbury, P.
|
Morris, D.
|
Nicholas, G.
| +22
Wird geladen...
3
Lung cancer in never smokers from the Princess Margaret Cancer Centre
enthalten in:
Oncotarget
| 2018
von
Korpanty, G.
|
Kamel-Reid, S.
|
Pintilie, M.
| +9
Wird geladen...
4
Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC)
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2017
von
Labbé, C.
|
Cabanero, M.
|
Korpanty, G.
| +14
Wird geladen...
5
Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer
enthalten in:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
| 2017
von
Doherty, M.
|
Korpanty, G.
|
Tomasini, P.
| +14
Wird geladen...
6
Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome
enthalten in:
Oncotarget
| 2017
von
Korpanty, G.
|
Eng, L.
|
Qiu, X.
| +16
Wird geladen...
7
ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism
enthalten in:
Clinical lung cancer
| 2017
von
Zer, A.
|
Moskovitz, M.
|
Hwang, D.
| +13
CommentIn: Clin Lung Cancer. 2018 Jan;19(1):e71-e72. - PMID 28818428
Wird geladen...
8
Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC)
enthalten in:
Lung cancer
| 2017
von
Labbé, C.
|
Cabanero, M.
|
Korpanty, G.
| +14
Wird geladen...
9
Biomarkers That Currently Affect Clinical Practice in Lung Cancer : EGFR, ALK, MET, ROS-1, and KRAS
enthalten in:
Frontiers in oncology
| 2014
von
Korpanty, G.
|
Graham, D.
|
Vincent, M.
| +1
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
9
Aufsätze
8
E-Artikel
8
E-Ressourcen
1
Gedruckte Aufsätze
Zeitschriftentitel
2
Lung cancer (Amsterdam, Netherlands)
2
Oncotarget
1
Clinical colorectal cancer
1
Clinical lung cancer
1
Frontiers in oncology
1
Lung cancer
1
Radiotherapy and oncology : journal of the Euro...
Alle anzeigen ...
weniger ...
Thema
8
Journal Article
4
Non-small cell lung cancer
3
EC 2.7.10.1
3
EGFR
2
ALK protein, human
2
Anaplastic Lymphoma Kinase
2
Clinical Trial, Phase II
2
ErbB Receptors
2
Randomized Controlled Trial
2
Receptor Protein-Tyrosine Kinases
2
Research Support, Non-U.S. Gov't
2
Survival
2
TP53
2
Tyrosine kinase inhibitors
1
04Q9AIZ7NO
1
15H5577CQD
1
2S9ZZM9Q9V
1
ALK
1
ALK translocation
1
Anaplastic lymphoma kinase (ALK)
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3
2018
5
2017
1
2014
Erscheinungsjahr(e)
Von:
Bis:
Sprache
9
Englisch
Haven't found what you're looking for?
Wird geladen...